Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    AREN0533
Show Display Options
Rank Status Study
1 Active, not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
Conditions: Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q;   Stage IV Wilms Tumor
Interventions: Drug: doxorubicin hydrochloride;   Drug: liposomal vincristine sulfate;   Procedure: conventional surgery;   Radiation: 3-dimensional conformal radiation therapy;   Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: etoposide

Indicates status has not been verified in more than two years